A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

  • STATUS
    Recruiting
  • End date
    Dec 31, 2028
  • participants needed
    200
  • sponsor
    The Second Hospital of Shandong University
Updated on 19 February 2024
cancer
esophageal cancer
esophagectomy
ivor
thoracic surgery
esophagus cancer

Summary

Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical

approaches

MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.

Details
Condition Esophageal Diseases, Esophageal Cancer, Esophageal Cancer, head and neck cancer, head and neck cancer
Age 30-80 years
Treatment MIE Ivor- Lewis, MIE McKeown
Clinical Study IdentifierNCT04217239
SponsorThe Second Hospital of Shandong University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

(I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary
function
(II) Patients with lower thoracic esophageal tumors and esophageal- gastric
junction tumor
(III) Patients without a previous history of cancer
(IV) Patients without a previous history of neck or chest surgery

Exclusion Criteria

(I) cardiopulmonary function not good enough for surgery
(II) Patients with hybrid MIE
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.